BPA Call HHSI239200710514B-HHSI2397010051409

Ortho-Clinical Diagnostics Inc. has been awarded a $169,280 fixed-price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The order is for 4561436224 units of ANTI-E BIOCLONE 1X5ML reagents to be delivered from Ortho-Clinical's facility in Raritan, New Jersey to an unspecified location by July 12, 2023. No set-aside designation or subcontractors are indicated. The Defense Logistics Agency Troop Support Medical supports the...

This is a $577,405.70 firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturer and supplier. The contract is for the provision of reagents and consumable supplies, with a period of performance ending on September 30, 2021. No set-aside designation was used for this award. Ortho-Clinical Diagnostics Inc. is a for-profit organization and self-certified HUBZone joint venture that specializes in...

This is a definitive contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract, valued at $880,348.70, is for the provision of clinical chemistry reagents under CLIN 0001. The contract has a firm fixed price structure and an ultimate completion date of January 20, 2030. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and a manufacturer of goods, and...

This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Ortho-Clinical Diagnostics Inc. The $106,044.52 contract is for the purchase of multiple reagent products to be used with the vendor's ProVue analyzer. This appears to be a recurring cost-per-test contract, as the description indicates the purchase of reagents for the vendor-owned analyzer. No set-aside designation was used. Ortho-Clinical Diagnostics Inc. is a for-profit...

Ortho-Clinical Diagnostics, Inc. was awarded a $1,156.61 fixed-price delivery order by the Defense Medical Supply Chain on July 14, 2025, for the supply of Anti-A Bioclone 15x10ml reagent products. The contract is scheduled for ultimate completion by August 4, 2025, and will be performed at the company's facility in Raritan, New Jersey. No small business set-aside designation was utilized for this award, indicating open competition among qualified vendors. This delivery order represents a...

Ortho-Clinical Diagnostics Inc. was awarded a $43,040 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The prime contractor will provide approximately 10 ml of anti-IgG reagent to the agency over a three-day period of performance in August 2023. The firm fixed price order was awarded to Ortho-Clinical Diagnostics Inc. for supply of the specified medical reagent to support the Defense Logistics Agency Troop Support...

Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $1,910.02 on August 6, 2025, for Anti-A Bioclone 15x10ml medical diagnostic reagents. The contract, which will be completed by August 27, 2025, was issued without a set-aside designation, indicating open competition. The funding originates from the Medical Supply Chain within the Department of Defense, with the place of performance located in Raritan, New Jersey. This delivery order...

This firm fixed price delivery order was awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc. for $1,016,444.96 to provide chemistry analyzers, reagents, supplies, training, and maintenance support. The award does not include a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a medical equipment manufacturer that has provided a range of diagnostic solutions and laboratory equipment to various federal agencies, including the Department of Veterans Affairs, Department...

This contract was awarded by the Department of the Army Medical Command to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer, on November 16, 2018. The $176,918.01 firm fixed price delivery order is for in vitro diagnostic reagents and test kits. No set-aside was used. Ortho-Clinical Diagnostics provides a range of diagnostic solutions, including blood bank analyzers, chemistry analyzers, reagents, and test kits, to federal agencies such as the Department of Veterans...

The Defense Health Agency awarded a firm fixed-price delivery order contract to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company, for ORTHO-CLINICAL COST PER TEST REAGENTS AND VITROS LEASE. The contract has a potential value of $231,980.34 and runs through September 30, 2021. Ortho-Clinical Diagnostics provides a range of diagnostic solutions, including the QuickVue At HomeTM COVID-19 Test and VITROS immunodiagnostic and clinical chemistry systems, to federal agencies...